title: Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia ablation versus drugs for preventing ICD shocks: role of adjuvant antiarrhythmic drug therapy.
authors.affiliation: Main Line Health Heart Center and Lankenau Hospital, Wynnewood, PA 19096, USA.
authors.forename: Chinmay
authors.initials: C
authors.lastname: Patel
authors.forename: Gan-Xin
authors.initials: GX
authors.lastname: Yan
authors.forename: Dusan
authors.initials: D
authors.lastname: Kocovic
authors.forename: Peter R
authors.initials: PR
authors.lastname: Kowey
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D017115:Catheter Ablation; D017024:Chemotherapy, Adjuvant; D016757:Death, Sudden, Cardiac / Q000209:etiology / Q000517:prevention & control*; D017147:Defibrillators, Implantable / Q000009:adverse effects*; D004554:Electric Countershock / Q000009:adverse effects* / Q000295:instrumentation; D004868:Equipment Failure; D019317:Evidence-Based Medicine; D006801:Humans; D011788:Quality of Life; D055502:Secondary Prevention; D017180:Tachycardia, Ventricular / Q000150:complications / Q000628:therapy*; D016896:Treatment Outcome; D014693:Ventricular Fibrillation / Q000150:complications / Q000628:therapy*
chemical_list: D000889:Anti-Arrhythmia Agents